English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine Healthcare & Pharm
雲頂新耀耐賦康入選《2024版KDIGO指南草案》 中期業績強勁增長 展現行業領軍地位
Oct 02, 2024 10:05 HKT
GEN Announces Positive Phase 2 Clinical Trial Results for GN-037 Topical Cream in Patients With Mild to Moderate Plaque Psoriasis
Sep 25, 2024 21:00 HKT
康哲藥業:磷酸蘆可替尼乳膏(白癜風)中國上市許可申請已獲受理
Sep 24, 2024 21:46 HKT
DEXIS Digital Ecosystem Expands With Three New Innovations To Streamline and Connect Dental Workflows
Sep 24, 2024 21:30 HKT
康哲药业:磷酸芦可替尼乳膏(白癜风)中国上市许可申请已获受理
Sep 24, 2024 21:20 HKT
China Medical System: New Drug Application for Vitiligo Indication of Ruxolitinib Phosphate Cream Accepted in China
Sep 24, 2024 21:00 HKT
Ripple Therapeutics Announces Collaboration and Option-to-License Agreement with AbbVie to Develop Next-Generation Therapies for Glaucoma Management
Sep 17, 2024 20:30 HKT
君聖泰醫藥亮相香港國際生物科技論壇
Sep 17, 2024 15:00 HKT
君聖泰醫藥亮相香港國際生物科技論壇
Sep 16, 2024 14:53 HKT
君圣泰医药亮相香港国际生物科技论坛
Sep 13, 2024 18:22 HKT
EASD 2024 | 君圣泰医药口头报告熊去氧胆小檗碱(HTD1801)在T2DM中的两项事后分析
Sep 11, 2024 11:51 HKT
EASD 2024 | HighTide Therapeutics Presents Oral Reports of Phase 2 Studies, Highlighting Benefits of Berberine Ursodeoxycholate (HTD1801)
Sep 11, 2024 11:34 HKT
EASD 2024 | 君聖泰醫藥口頭報告熊去氧膽小檗碱(HTD1801)在T2DM中的兩項事後分析
Sep 11, 2024 11:16 HKT
How Much Do Vegan Diets Improve the Health of Dogs?
Sep 06, 2024 07:00 HKT
Celeb-red our Nation's Birthday with LAC!
Aug 31, 2024 09:00 HKT
Tong Ren Tang Chinese Medicine Announces 2024 Interim Results
Aug 30, 2024 20:50 HKT
同仁堂國藥宣佈2024年中期業績
Aug 30, 2024 20:31 HKT
Fosun Pursues Solid Business Development with Predictable Profit
Aug 30, 2024 13:30 HKT
复星国际未来产业发展和赢利更可预期
Aug 30, 2024 12:43 HKT
復星國際未來產業發展和贏利更可預期
Aug 30, 2024 12:28 HKT
<< Previous  Next >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: